Berlin Cures Announces Formation of Scientific Advisory Board

ZUG, Switzerland, May 23, 2018 /PRNewswire/ — Drug developer Berlin Cures today announced the formation of a Scientific Advisory Board (SAB) and the appointment of its first two members, Prof. Beda M. Stadler and Prof. Wilhelm Vetter, to help advance the clinical development of BC 007,…

Source: https://www.prnewswire.com/news-releases/berlin-cures-announces-formation-of-scientific-advisory-board-300652808.html

About the Author

has written 38431 stories on this site.

Copyright © 2010 Business and Corporate News.